Lumida
/SGHT
⌘K
Sight Sciences Inc

Sight Sciences Inc

SGHT
$5.03USD-3.27%-0.17 today

MARKET CAP

273.7M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$3
$9

AI Summary

Stalk
Buy NowMedium

SGHT remains in a Stage 2 advancing phase, underpinned by an active Lockout Rally that has driven price above the 9 and 21 EMAs on rising volume. The medium-term bias is bullish, supported by a HH/HL sequence off the March low, while the long-term trend stays intact. Short-term execution is favorable now under the Lockout Rally override, so participation at shallow pullbacks into the EMAs aligns with continuation dynamics.

  • Q1 2026 revenue $19.7M, up 13% YoY across glaucoma and dry eye.
  • Raised 2026 revenue guidance to $83–89M, implying 7–15% growth.
  • Negative earnings yield and profitability factors signal weak returns.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRIC
TREND